glp-1 agonist oral New Guidelines for Type 2 Diabetes in 2025 In the ATTAIN-1 phase 3,
Description
However, renal effects of GLP-1 in heart failure (HF) has not been elucidated
The GLP-1 receptor assay is a powerful tool for the identification of GLP-1 receptor agonists aimed at treating obesity and type 2 diabetes
no major safety concerns were observed
This review describes the basic and clinical pharmacology of orally administered semaglutide
Moreover, the addition of finerenone to this combination therapy could potentially provide stronger cardiorenal protective benefits
